Guidant Ancure Endograft stent defect website launched - www.ancure-defects.com

A new Guidant Ancure Endograft stent defect website was launched today - www.ancure-defects.com

London, England (PRWEB) August 7, 2004 -- Guidant Ancure Endograft stent defect website was launched today - www.ancure-defects.com

On June 16, 2003, www.guidant.com [Guidant Corporation] removed the http://www.ancure-defects.com [Ancure Endograft Stent] after pleading guilty to 10 felony counts related to dangerous practices involving the popular medical device.

The Guidant Ancure Endograft is used in the treatment of abdominal aortic aneurysms. The stent graft device was inserted into the troubled artery and inflated to provide support and reinforcement for the blood flow. This procedure was an alternative to a more invasive surgery of the abdomen.

Estimates indicate that the http://www.ancure-defects.com [Ancure Endograft failed]in as many as 6,000 of the 18,000 patients who received the device. In spite of federal regulations requiring Guidant Corporation to notify the http://www.fda.gov [FDA] when it becomes aware of serious injuries or death possibly related to their product, Guidant intentionally misled the FDA.

The clearly lays out the back ground issues, current available http://www.ancure-defects.com/information.htm [Ancure Endograph information] and details the http://www.ancure-defects.com/malfunctions.htm [Ancure Endograph Class actions].